🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 22 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/09/2004 | 42,61 | 43,23 | 42,37 | 43,02 | +1,23% | 2,04% | 4.607.008 |
| 01/09/2004 | 42,55 | 42,64 | 42,10 | 42,50 | -0,96% | 1,28% | 5.221.555 |
| 31/08/2004 | 42,84 | 43,15 | 42,47 | 42,91 | +0,09% | 1,58% | 5.777.414 |
| 30/08/2004 | 42,80 | 43,59 | 42,80 | 42,87 | -0,49% | 1,85% | 5.036.898 |
| 27/08/2004 | 42,99 | 43,21 | 42,92 | 43,08 | +0,22% | 0,67% | 5.897.201 |
| 26/08/2004 | 43,37 | 43,42 | 42,66 | 42,99 | -2,11% | 1,74% | 9.650.298 |
| 25/08/2004 | 44,23 | 44,70 | 43,22 | 43,91 | -0,71% | 3,37% | 7.762.746 |
| 24/08/2004 | 44,29 | 44,52 | 44,06 | 44,23 | +0,28% | 1,03% | 3.711.073 |
| 23/08/2004 | 44,80 | 44,85 | 44,06 | 44,10 | +0,30% | 1,77% | 3.886.822 |
| 20/08/2004 | 43,21 | 44,30 | 43,21 | 43,97 | +1,45% | 2,54% | 5.898.982 |
| 19/08/2004 | 43,47 | 43,66 | 43,04 | 43,34 | -0,85% | 1,43% | 3.925.494 |
| 18/08/2004 | 42,61 | 43,71 | 42,61 | 43,71 | +1,87% | 2,60% | 5.520.654 |
| 17/08/2004 | 42,94 | 42,99 | 42,63 | 42,91 | -0,22% | 0,82% | 5.392.694 |
| 16/08/2004 | 42,37 | 43,08 | 42,37 | 43,01 | +1,08% | 1,69% | 3.747.543 |
| 13/08/2004 | 42,70 | 42,89 | 42,31 | 42,55 | -0,45% | 1,36% | 3.043.811 |
| 12/08/2004 | 42,75 | 43,10 | 42,56 | 42,74 | -0,47% | 1,27% | 4.507.553 |
| 11/08/2004 | 42,61 | 43,02 | 42,54 | 42,94 | +0,78% | 1,14% | 5.289.361 |
| 10/08/2004 | 42,27 | 42,61 | 41,91 | 42,61 | +1,32% | 1,65% | 4.132.998 |
| 09/08/2004 | 41,75 | 42,41 | 41,58 | 42,05 | +1,08% | 1,99% | 4.812.102 |
| 06/08/2004 | 41,98 | 42,18 | 41,47 | 41,60 | -1,87% | 1,68% | 6.396.992 |
| 05/08/2004 | 42,74 | 42,89 | 42,22 | 42,40 | -1,05% | 1,56% | 4.706.987 |
| 04/08/2004 | 42,86 | 43,10 | 42,61 | 42,84 | +0,07% | 1,16% | 4.610.362 |
| 03/08/2004 | 43,15 | 43,35 | 42,80 | 42,81 | -1,32% | 1,28% | 5.477.477 |
| 02/08/2004 | 43,23 | 43,61 | 43,04 | 43,39 | +0,26% | 1,30% | 4.690.848 |
| 30/07/2004 | 43,08 | 43,61 | 42,86 | 43,27 | -0,11% | 1,73% | 4.230.252 |
| 29/07/2004 | 42,97 | 43,70 | 42,72 | 43,32 | +0,84% | 2,29% | 5.559.954 |
| 28/07/2004 | 43,03 | 43,05 | 42,35 | 42,96 | -0,04% | 1,64% | 5.822.688 |
| 27/07/2004 | 42,98 | 43,00 | 42,54 | 42,98 | +0,09% | 1,07% | 5.450.962 |
| 26/07/2004 | 43,09 | 43,32 | 42,48 | 42,94 | -0,35% | 1,95% | 6.477.374 |
| 23/07/2004 | 43,23 | 43,50 | 42,60 | 43,09 | -0,44% | 2,10% | 5.767.878 |